Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.42 USD | -0.02% | -0.02% | +122.94% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
- Stock Market
- Equities
- FUSN Stock
- News FUSN PHAR
- Fusion Pharmaceuticals : Morgan Stanley Adjusts Price Target on Fusion Pharmaceuticals to $19 From $20, Maintains Overweight Rating